EndyMed Medical Receives FDA Clearance for Painless, Non-invasive Anti-Wrinkle Treatment System
Posted on: Monday, 17 August 2009, 07:30 CDT
The EndyMed PRO implements the third generation 3DEEP(TM) radio frequency
(RF) technology which uses multiple, phase controlled sources, and is the
first product of this type to receive clearance to be marketed in the
3DEEP(TM) uniquely controls the power, depth and 3-dimensional pattern of RF energy delivered to the skin. The 3DEEP technology results in minimal surface energy flow, thus eliminating the need for cooling, and providing an effective contouring treatment that is personalized, safe & totally painless.
"FDA clearance establishes our company as a significant player in the
worldwide aesthetics market," said
In a multicenter clinical study examining the safety and efficacy of the EndyMed PRO(TM) wrinkle reduction system, dermatological evaluation concluded that a significant reduction of wrinkle grading was evidenced in more than 80 percent of the treated patients, three months after the end of the treatment.
The advanced EndyMed PRO is equipped with a range of features to assure effective and safe treatment:
- Non-invasive, yet highly effective therapy for the reduction of wrinkles and rhytides. - Customized treatment parameters - Optimal safety, with no pain and no side effects - Short treatment with no downtime - Noticeable immediate improvement - Long term resultsAbout EndyMed Medical
EndyMed Medical Ltd., established in 2007, is a medical technology
company that designs, develops, and commercializes noninvasive, RF-energy
based aesthetic treatment systems for the professional market. EndyMed was
established and continues to be guided by an experienced management, clinical
and development team. The company is characterized by its fast, innovative,
market-oriented R&D, targeting the fastest growing segments of the medical
aesthetic market. The EndyMed PRO will be marketed exclusively in
SOURCE EndyMed Medical Ltd.
Source: PR Newswire
Related Articles
- Doshion Limited Conferred the Frost & Sullivan 2009 Brand Development Strategy Leadership Award for Indian Water and Wastewater Treatment Equipment Market
- Innovative and Affordable Products Uplift Prospects for Point-of-Use Water Treatment Systems Market in India, Finds Frost & Sullivan
- Growth Opportunity in Brazil's Varicose Vein Treatment Device Market
- Water Contamination and High Disposable Incomes Create Significant Growth Potential in the Indian Residential Water Treatment Systems Market - Finds Frost & Sullivan
- Discover the Next Generation Treatments and Market Dynamics With Innovations in the Management of Diabetes
- Kingfisher Healthcare Wins Clearance to Market KFH Energy in US
- Nexen Presents at RBC Capital Markets' Canadian Energy Summit
- The Need for Water and Environmental Conservation Emphasised By Legislation is Likely to Aid Growth of Water Treatment Chemicals Market
- PAREXEL Appoints Glenn C. Van Deusen As Corporate Vice President and General Manager of Medical Marketing Services
- Advanced Medical Marketing Communications Hires Michael K. Rock As Director, Medical Affairs
 |
 |
User Comments (0)
RSS Feeds